Filter By

Clear Filters

December 14, 2011

Yaz/Yasmin, NuvaRing Use: Study Finds Increased Blood Clot Risk

The US Food and Drug Administration (FDA) recently released the final report of an FDA-funded study regarding the risk of venous thromboembolism (VTE) in women taking hormonal contraceptives, finding that women who take drospirenone-containing birth-control pills are significantly more likely to develop a VTE than women using standard low-estrogen birth control pills.

Read More